Glucose-dependent enhancement of spontaneous phasic contraction is suppressed in diabetic mouse portal vein: Association with diacylglycerol-protein kinase C pathway

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 3, 2004, Pages 1263-1272

  Nobe, Koji ^a   Suzuki, Hikaru ^a   Sakai, Yasushi ^a   Nobe, Hiromi ^a   Paul, Richard J ^b   Momose, Kazutaka ^a  

^a SHOWA UNIVERSITY   (Japan)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM; DIACYLGLYCEROL; GLUCOSE; PHOSPHATIDYLINOSITOL; PROTEIN KINASE C; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; HYPERGLYCEMIA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; DIABETES MELLITUS; DIACYLGLYCEROL KINASE; DIGLYCERIDES; GLUCOSE; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PHOSPHATIDYLINOSITOLS; PORTAL VEIN; PROTEIN KINASE C; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 2442718936     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.062802     Document Type: Article

References (31)

1. Babazono T, Kapor-Drezgic J, Dlugosz JA, and Whiteside C (1998) Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 47:668-676.
2. Chang AY and Schneider DI (1970) Abnormalities in hepatic enzyme activities during development of diabetes in db mice. Diabetologia 6:274-278.
3. Chaudhuri A (2002) Vascular reactivity in diabetes mellitus. Curr Diab Rep 2:305-310.
4. Coleman DL and Hummel KP (1967) Studies with the mutation, diabetes, in the mouse. Diabetologia 3:238-248.
5. Conrad KP, Barrera SA, Friedman PA, and Schmidt VM (1991) Evidence for attenuation of myo-inositol uptake, phosphoinositide turnover and inositol phosphate production in aortic vasculature of rats during pregnancy. J Clin Investig 87: 1700-1709.
6. Dawson RM, Irvine RF, Bray J, and Quinn PJ (1984) Long-chain unsaturated diacylglycerols cause a perturbation in the structure of phospholipid bilayers rendering them susceptible to phospholipase attack. Biochem Biophys Res Commun 125:836-842.
7. Desbuquois B and Aurbach GD (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732-738.
8. Ganz MB and Seftel A (2000) Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiol Endocrinol Metab 276:E146-E152.
9. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, and King GL (1994) Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267:E369-E379.
10. Kanoh H, Yamada K, Sakane F, and Imaizumi T (1989) Phosphorylation of diacylglycerol kinase in vitro by protein kinase C. Biochem J 258:455-462.
11. Khan AH and Pessin JE (2002) Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 45:1475-1483.
12. Koya D and King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866.
13. Lee MW and Severson DL (1994) Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol 257:C659-C678.
14. Lee TS, Saltsman KA, Ohashi H, and King GL (1989) Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86:5141-5145.
15. MacMathuna PM (1992) Mechanisms and consequences of portal hypertension. Drugs 44:1-13; discussion 70-12.
16. Mathis DR, Liu SS, Rodrigues BB, and McNeill JH (2000) Effect of hypertension on the development of diabetic cardiomyopathy. Can J Physiol Pharmacol 78:791-798.
17. Meyerovitch J, Backer JM, and Kahn CR (1989) Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats. J Clin Investig 84:976-983.
18. Meyerovitch J, Rothenberg P, Shechter Y, Bonner-Weir S, and Kahn CR (1991) Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. J Clin Investig 87:1286-1294.
19. Miwa T, Endou M, and Okumura F (1997) Prostaglandin E1 potentiation of the spontaneous phasic contraction of rat isolated portal vein by a cyclopiazonic acid-sensitive mechanism. Br J Pharmacol 120:1419-1426.
20. Nobe K, Aizawa H, Ohata H, and Momose K (1995) Protein kinase C is involved in translocation of diacyglycerol kinase induced by carbachol in guinea pig taenia coli. Biochem Pharmacol 50:591-599.
21. Nobe K, Ohata H, and Momose K (1993) Effect of diacylglycerol kinase inhibitor, R59022 on cytosolic free calcium level and force development in guinea pig taenia coli. Res Commun Chem Pathol Pharmacol 81:331-343.
22. Nobe K, Ohata H, and Momose K (1997) Receptor-mediated diacylglycerol kinase translocation dependent on both transient increase in the intracellular calcium concentration and modification by protein kinase C. Biochem Pharmacol 53:1683-1694.
23. Nobe K, Sakai Y, Nobe H, Takashima J, Paul RJ, and Momose K (2003) Enhancement effect under high-glucose conditions on U46619-induced spontaneous phasic contraction in mouse portal vein. J Pharmacol Exp Ther 304:1129-1142.
24. Ozturk Y, Altan VM, and Yildizoglu-Ari N (1996) Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 48:69-112.
25. Park JY, Ha SW, and King GL (1999) The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int 19 (Suppl 2):S222-S227.
26. Pillay TS and Makgoba MW (1991) Molecular mechanisms of insulin resistance. S Afr Med J 79:607-613.
27. Rossi F, Grzeskowiak M, Della Bianca V, and Sbarbati A (1991) De novo synthesis of diacylglycerol from glucose. A new pathway of signal transduction in human neutrophils stimulated during phagocytosis of beta-glucan particles. J Biol Chem 266:8034-8038.
28. Silva CL, Lenzi HL, Silva VF, Paulo FO, and Noel F (2003) Cellular mechanisms involved in the increased contraction of portal veins from Schistosoma mansoni-infected mice. Parasitol Res 89:16-22.
29. Szule JA, Fuller NL, and Rand RP (2002) The effects of acyl chain length and saturation of diacylglycerols and phosphatidylcholines on membrane monolayer curvature. Biophys J 83:977-984.
30. Vicario P, Brady EJ, Slater EE, and Saperstein R (1987) Insulin receptor tyrosine kinase activity is unaltered in ob/ob and db/db mouse skeletal muscle membranes. Life Sci 41:1233-1241.
31. Wakino S, Kintscher U, Liu Z, Kim S, Yin F, Ohba M, Kuroki T, Schonthal AH, Hsueh WA, and Law RE (2001) Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells. J Biol Chem 276:47650-47657.